WHO ICTRP trial

Crystalloids or colloids in patients with severe sepsis: effects on hemodynamics…

EUCTR2006-004350-25-FR · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2006-004350-25-FR
Public title Crystalloids or colloids in patients with severe sepsis: effects on hemodynamics and tolerability of enteral nutrition - CRYSTMAS protocol (CRYSTalloids Morbidity Associated with severe Sepsis)
Scientific title Crystalloids or colloids in patients with severe sepsis: effects on hemodynamics and tolerability of enteral nutrition - CRYSTMAS protocol (CRYSTalloids Morbidity Associated with severe Sepsis)
Primary sponsor Fresenius Kabi Deutschland GmbH
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries France;Germany
Conditions Severe sepsis MedDRA version: 8.1 Level: LLT Classification code 10040070 Term: Septic shock
Interventions Trade Name: Voluven Pharmaceutical Form: Solution for infusion Concentration unit: g/l gram(s)/litre Concentration type: equal Concentration number: 60- Trade Name: Chlorure de sodium 0,9% Fresenius Pharmaceutical Form: Solution for…
Registration date Dec 29, 2006
Target size 180
Secondary IDs 06-HE06-01
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations